Levin Capital Strategies’s CVS Health CVS Stock Holding History

Levin Capital Strategies’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,000	Closed	-$1.04M	–	284
2023 Q2	$1.04M	Buy	+15,000	New	+$1.07M	0.12%	88

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Levin Capital Strategies's CVS Position: Q4 2024 in Review

Levin Capital Strategies sold out of CVS Health (CVS) in Q4 2024, closing a stake of 6,000 shares — an estimated $377K sold.

Levin Capital Strategies first reported a position in CVS in Q4 2014 and held it in 37 quarters. The position peaked at $64.3M in Q2 2017. 1,670 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Levin Capital Strategies reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Levin Capital Strategies sold 6,000 CVS Health shares in Q4 2024, an estimated $377K.
Levin Capital Strategies first reported a position in CVS Health in Q4 2014 and held it in 37 quarters.
Levin Capital Strategies's CVS Health position peaked at $64.3M in Q2 2017.
1,670 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Levin Capital Strategies's 13F filing for Q4 2024, filed 5 Feb 2025.